Leuko, founded by a research team at MIT, is giving doctors a noninvasive way to monitor cancer patients’ health during chemotherapy — no blood tests needed.
Since 2020, K-CAI has innovated and tested climate policies in more than 35 countries and supported scale-ups that have reached over 15 million people.